XML 78 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies - Additional Information (Details)
$ in Thousands
12 Months Ended
Sep. 03, 2019
USD ($)
Oct. 04, 2018
USD ($)
ft²
optionToExtend
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Operating Leased Assets [Line Items]        
Operating lease, cost     $ 12,800  
Operating lease, payments     $ 12,000  
Number of option to extend | optionToExtend   1    
Weighted average remaining term of operating leases (in years)     10 years 7 months 2 days  
Weighted average discount rate of operating leases (as a percent)     737.00%  
Verily Life Sciences LLC        
Operating Leased Assets [Line Items]        
Term of development agreement (in months) 24 months      
Upfront fee related to development agreement       $ 5,000
Additional aggregate milestone payments related to development agreement $ 12,750      
Milestone payments paid related to development agreement       $ 1,000
Research and development expense related to development agreement     $ 7,000  
Accrued liabilities related to development agreement     $ 4,000  
San Francisco | Office Lease        
Operating Leased Assets [Line Items]        
Lease rentable area | ft²   117,560    
Renewal term of lease (in years)   5 years    
San Francisco | Standby Letters of Credit | Office Lease        
Operating Leased Assets [Line Items]        
Current borrowing capacity under credit facility   $ 6,900    
San Francisco | Maximum | Office Lease        
Operating Leased Assets [Line Items]        
Tenant improvement allowance   $ 2,400